Skip to content

Anixa Biosciences Inc

ANIX· NasdaqCore metricsCIK 715446

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -3.60%
Market cap
$93.17M
34.76M shares
Filings
983
$210.00K
FY 2024±0.0% FY24 yoy
-$2.61M
Q3 2026N/M FY25 yoy
-$2.74M
Q3 2026N/M FY25 yoy
-$6.19M
FY 2021derivedN/M FY20 yoy
-$0.08
Q3 2026N/M FY25 yoy
$1.40M
Q3 2026−2.1% FY25 yoy
$93.17M
—
—
6.4×
—
—

FY2025 figures · derived

Price

$2.6841.48%$1.90past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$210.00KFY 2024
$9.26M0FY 2011FY 2016FY 2024
PeriodEndedValueKindSource trail
FY 20242024-10-31$210,000reported
FY 20232023-10-31$210,000reported
FY 20212021-10-31$512,000reported
FY 20192019-10-31$250,000reported
FY 20182018-10-31$1,112,500reported
FY 20172017-10-31$362,500reported
FY 20162016-10-31$300,000reported
FY 20152015-10-31$9,255,000reported
FY 20142014-10-31$3,667,320reported
FY 20132013-10-31$388,850reported
FY 20122012-10-31$940,010 revisedreported
FY 20112011-10-31$1,003,193reported

Capital returns

Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2024—$6.00K$6.00K—32.20M sh+1.6%—

Segments

Segments
Operating income by Segments, FY2024 to FY2025FY2024FY2025
LineFY2025ShareChange
Other-$54.00K—N/M
CAR-T Therapeutics-$4.45M—N/M
Cancer Vaccines-$7.39M—N/M
Total-$11.70M

From the 10-K filed Jan 12, 2026ANIX

Pharmaceutical preparations

Anixa Biosciences Inc is the 293rd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Anixa Biosciences Inc · CIK 715446 · Engraved from SEC EDGAR